Javascript must be enabled to continue!
A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved area
View through CrossRef
Introduction Sickle cell disease (SCD) is the most common inherited haematological disease, with potentially devastating complications. Improvements in therapies have increased the life span of patients with SCD, but this is contingent on receiving timely evidence-based medical care, including regular evaluations with haematologists, disease-specific education and psychosocial care. Our objective was to evaluate the feasibility of utilizing telemedicine for the provision of subspecialty paediatric SCD care in a rural medically underserved area. Methods This was a cross-sectional, observational, feasibility study. All patients 0â21 years old with SCD seen at Riley Hospital for Children Comprehensive Pediatric Sickle Cell Clinic who lived within 30 miles of the spoke telemedicine facility were eligible for recruitment. The Telehealth Satisfaction Scale (TeSS) was adapted for the SCD population and administered at each visit. Results Ten SCD patients, ranging in age from 10 months to 18 years old, initiated telemedicine visits during this timeframe. Some 60% were lost to follow-up or did not attend >50% of scheduled visits prior to beginning telemedicine visits. Following initiation of telemedicine, all Hb SS patients were started and/or maintained on hydroxyurea. Nine out of 10 patients who participated during this timeframe had a 100% follow-up rate. All who participated rated the comfort and ease of using the telehealth system as good or excellent and would do a telemedicine visit again. Discussion This study provides critical information to determine the feasibility and acceptability of a telemedicine intervention to aid in SCD care. To our knowledge, this is the first study to examine the effectiveness of telemedicine to deliver comprehensive paediatric SCD care. Future research with a larger sample size is needed to confirm findings of our study, including expansion of telemedicine sites to include more urban areas.
SAGE Publications
Title: A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved area
Description:
Introduction Sickle cell disease (SCD) is the most common inherited haematological disease, with potentially devastating complications.
Improvements in therapies have increased the life span of patients with SCD, but this is contingent on receiving timely evidence-based medical care, including regular evaluations with haematologists, disease-specific education and psychosocial care.
Our objective was to evaluate the feasibility of utilizing telemedicine for the provision of subspecialty paediatric SCD care in a rural medically underserved area.
Methods This was a cross-sectional, observational, feasibility study.
All patients 0â21 years old with SCD seen at Riley Hospital for Children Comprehensive Pediatric Sickle Cell Clinic who lived within 30 miles of the spoke telemedicine facility were eligible for recruitment.
The Telehealth Satisfaction Scale (TeSS) was adapted for the SCD population and administered at each visit.
Results Ten SCD patients, ranging in age from 10 months to 18 years old, initiated telemedicine visits during this timeframe.
Some 60% were lost to follow-up or did not attend >50% of scheduled visits prior to beginning telemedicine visits.
Following initiation of telemedicine, all Hb SS patients were started and/or maintained on hydroxyurea.
Nine out of 10 patients who participated during this timeframe had a 100% follow-up rate.
All who participated rated the comfort and ease of using the telehealth system as good or excellent and would do a telemedicine visit again.
Discussion This study provides critical information to determine the feasibility and acceptability of a telemedicine intervention to aid in SCD care.
To our knowledge, this is the first study to examine the effectiveness of telemedicine to deliver comprehensive paediatric SCD care.
Future research with a larger sample size is needed to confirm findings of our study, including expansion of telemedicine sites to include more urban areas.
Related Results
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Abstract
Introduction
Telemedicine is the remote delivery of healthcare services using information and communication technologies and has gained global recognition as a solution to...
The Telemedicine Experience for Individuals with Sickle Cell Disease
The Telemedicine Experience for Individuals with Sickle Cell Disease
Abstract
Introduction
Individuals with Sickle Cell Disease (SCD) require regular, and specialized treatment to manage their health. The COVID-19 pande...
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country
Background: Sickle cell disease in pregnancy is associated with high maternal and fetal mortality. However, studies reporting pregnancy, fetal, and neonatal outcomes in women with ...
Selected Testing of Newborns for Sickle Cell Disease
Selected Testing of Newborns for Sickle Cell Disease
There are two main reasons for sickle cell testing: the early detection of those with sickle cell disease and the detection of the carrier state, sickle cell trait. The mortality o...
Exchange Transfusion In Adult Patients With Sickle Cell Disease With Refractory Vaso-Occlusive Crises
Exchange Transfusion In Adult Patients With Sickle Cell Disease With Refractory Vaso-Occlusive Crises
Sickle cell disease occurs in 1/500 African-American births. Pain is one of the most common complications of sickle cell disease and is associated with depression, anxiety, decreas...
Intermittent Fasting in Sickle Cell Disease: Case series and Review of Literature
Intermittent Fasting in Sickle Cell Disease: Case series and Review of Literature
Abstract
â
Presentation Date: 6/8/2024
Presentation Start Time: 6:00:00âPM
...
Clinical Evaluation of T-AYU-HM Premium in Sickle cell Anemia Patients: A Retrospective Study
Clinical Evaluation of T-AYU-HM Premium in Sickle cell Anemia Patients: A Retrospective Study
Background: The orphan status of sickle cell invites many researchers toward drug development in the past decade. A substantial number of clinical trials either understudies or in ...
Evaluating Clinical Outcomes and Physician Adoption of Telemedicine for Chronic Disease Management: Population-Based Retrospective Cohort Study (Preprint)
Evaluating Clinical Outcomes and Physician Adoption of Telemedicine for Chronic Disease Management: Population-Based Retrospective Cohort Study (Preprint)
BACKGROUND
In recent years, the use and impact of telemedicine for providing health care services to patients has increased, reducing the requirement for ph...

